Literature DB >> 21917260

Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice.

Claire Arnaud1, Laureline Poulain, Patrick Lévy, Maurice Dematteis.   

Abstract

RATIONALE: Obstructive sleep apnea results in nocturnal intermittent hypoxia (IH) as a main trigger for cardiovascular morbidity, including atherosclerosis. IH induces hemodynamic, hormono-metabolic and also immuno-inflammatory alterations that could differentially contribute to atherosclerosis. Our study aimed at examining their respective contribution to the proatherogenic role of IH in atherosclerosis-prone mice.
METHODS: Fifteen-week-old male apolipoprotein E-deficient (ApoE(-/-)) mice fed on a high-cholesterol diet (HCD) for 6 weeks and exposed for the last 14 days to IH (21-5% FiO(2), 60s cycle, 8h/day) or air, were investigated for aortic atherosclerosis and lipid alterations. Then IH proatherogenicity was assessed in 15- and 20-week-old ApoE(-/-) mice fed on a standard-chow diet (SCD) exposed to IH or air for 14 days and assessed for atherosclerosis, lipid, hemodynamic and inflammation alterations.
RESULTS: IH aggravated atherosclerosis in HCD-fed mice, whereas the extremely high cholesterol levels due to HCD were not different between normoxic and hypoxic animals. In SCD-fed mice, IH also aggravated atherosclerosis, more severely in 20 compared to 15-week-old animals. However, cholesterol levels that increased with IH were not different in the two SCD-fed groups. IH slightly elevated arterial blood pressure in 20-week-old animals only, and induced systemic and vascular inflammation, including increased splenocyte proliferation with decreased IL-10 secretion, and increased T-lymphocytes within atherosclerotic plaques.
CONCLUSIONS: A short IH exposure without HCD has proatherogenic effects. In contrast to blood pressure or plasma lipids which were slightly or inconstantly affected by IH, inflammation at systemic and vascular levels appears as a potential contributing factor to IH atherogenicity.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917260     DOI: 10.1016/j.atherosclerosis.2011.07.122

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  33 in total

1.  Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.

Authors:  Robert M Douglas; Karen Bowden; Jennifer Pattison; Alexander B Peterson; Joseph Juliano; Nancy D Dalton; Yusu Gu; Erika Alvarez; Toshihiro Imamura; Kirk L Peterson; Joseph L Witztum; Gabriel G Haddad; Andrew C Li
Journal:  J Appl Physiol (1985)       Date:  2013-08-29

Review 2.  Potential contributions of intimal and plaque hypoxia to atherosclerosis.

Authors:  Guo-Hua Fong
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

3.  Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor-κB kinase subunit β-dependent atherosclerosis in pulmonary arteries.

Authors:  Toshihiro Imamura; Jin Xue; Orit Poulsen; Dan Zhou; Michael Karin; Gabriel G Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-16       Impact factor: 3.619

Review 4.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

Review 5.  The polymorphic and contradictory aspects of intermittent hypoxia.

Authors:  Isaac Almendros; Yang Wang; David Gozal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

6.  Intermittent hypoxia induces murine macrophage foam cell formation by IKK-β-dependent NF-κB pathway activation.

Authors:  Toshihiro Imamura; Orit Poulsen; Gabriel G Haddad
Journal:  J Appl Physiol (1985)       Date:  2016-07-28

Review 7.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

8.  NF-κB and hypoxia: a double-edged sword in atherosclerosis.

Authors:  Xinghui Sun; Mark W Feinberg
Journal:  Am J Pathol       Date:  2012-09-20       Impact factor: 4.307

Review 9.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.

Authors:  Luciano F Drager; Qiaoling Yao; Karen L Hernandez; Mi-Kyung Shin; Shannon Bevans-Fonti; Jason Gay; Thomas E Sussan; Jonathan C Jun; Allen C Myers; Gunilla Olivecrona; Alan R Schwartz; Nils Halberg; Philipp E Scherer; Gregg L Semenza; David R Powell; Vsevolod Y Polotsky
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.